← Back to Search

Group Singing for Stroke Patients

N/A
Recruiting
Led By Joanne Loewy, DA
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will study the effects of communal singing on stroke patients and their caregivers. 40 post-stroke patients will be randomly assigned to 2 groups: the first group will receive 6 months of music therapy, while the second group will receive standard care.

Who is the study for?
This trial is for stroke survivors of any severity and their personal caregivers. There are no specific exclusion criteria, meaning it's quite open to anyone who has experienced a stroke.Check my eligibility
What is being tested?
The study is testing the effects of communal singing as a form of music therapy. Participants will be split into two groups: one will engage in group singing sessions for six months, while the other receives standard post-stroke care.See study design
What are the potential side effects?
Since this intervention involves communal singing, there aren't typical medical side effects; however, participants may experience emotional or psychological responses to music therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in mood and quality of life as indicated through saliva (cortisol and melatonin sampling)
Secondary outcome measures
Change in language aphasia outcome improvement
Other outcome measures
Change in motivation and verbal expression

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Communal singingExperimental Treatment1 Intervention
Participants in the study group will join the choir and participate in a weekly hour rehearsal for six months and will be assessed for aphasia, mood, and quality of life outcomes
Group II: ControlActive Control1 Intervention
The control group will not participate in the choir for the first six months. At the end of the six months study period, all participants will be evaluated again for changes in aphasia, language, mood and quality of life

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for stroke include thrombolytic therapy, which dissolves blood clots to restore blood flow to the brain, and mechanical thrombectomy, which physically removes clots. Rehabilitation therapies, such as physical, occupational, and speech therapy, aim to improve motor skills, daily functioning, and communication abilities. Communal singing, a form of music therapy, can enhance mood, cognitive function, and social interaction. These benefits are crucial for stroke patients as they can improve emotional well-being, cognitive recovery, and social reintegration, which are essential for overall rehabilitation and quality of life.

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
871 Previous Clinical Trials
527,183 Total Patients Enrolled
13 Trials studying Stroke
7,174 Patients Enrolled for Stroke
Joanne Loewy, DAPrincipal Investigator - Beth Israel Medical Center
Icahn School of Medicine at Mount Sinai
3 Previous Clinical Trials
564 Total Patients Enrolled

Media Library

Communal singing Clinical Trial Eligibility Overview. Trial Name: NCT02328573 — N/A
Stroke Research Study Groups: Communal singing, Control
Stroke Clinical Trial 2023: Communal singing Highlights & Side Effects. Trial Name: NCT02328573 — N/A
Communal singing 2023 Treatment Timeline for Medical Study. Trial Name: NCT02328573 — N/A
~5 spots leftby Apr 2025